EBITDA at other companies
Other financials
Where this comes from
Calculated from Arcutis Biotherapeutics, Inc.’s reported figures.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s EBITDA?
- Arcutis Biotherapeutics, Inc. (ARQT) reported EBITDA of -$8.53M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s EBITDA changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s EBITDA increased by 60.1% year-over-year, from -$21.4M to -$8.53M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s EBITDA?
- Over 3 years (2021 to 2024), Arcutis Biotherapeutics, Inc.'s EBITDA has grown at a -15.2% compound annual growth rate (CAGR), from -$206.08M to -$125.79M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.